Beyond Cancer Ltd, an affiliate of Beyond Air Inc XAIR, announced that the Phase 1 Study evaluating ultra-high concentration nitric oxide (UNO) in advanced,…
Beyond Air Inc (NASDAQ: XAIR)’s stock price has gone decline by -8.71 in comparison to its previous close of 2.41, however, the company has experienced a 2.33% increase in its stock price over the last five trading days. GlobeNewsWire reported 2023-10-04 that GARDEN CITY, N.Y. and HAMILTON, Be
Moreover, the 36-month beta value for XAIR is -0.29. Analysts have varying opinions on the stock, with 6 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.” The average price recommended by analysts for Beyond Air Inc (XAIR)
Long Island's highest paid executives newsday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsday.com Daily Mail and Mail on Sunday newspapers.